lobbying_activities: 2431907

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2431907	0af66202-d6b7-44f3-8222-f6533ead8c19	Q1	BRAEBURN INC. FORMERLY KNOWN AS BRAEBURN PHARMACEUTICALS INC	401104621	BRAEBURN INC FORMERLY KNOWN AS BRAEBURN PHARMACEUTICALS INC	2020	first_quarter	PHA	HR 4712, S3271 Fairness in Orphan Drug Exclusivity Act: General lobbying pertaining to opioid crisis; controlled substances and specialty pharmacies	HOUSE OF REPRESENTATIVES,SENATE		100000	0	0	2020-04-17T13:26:33.017000-04:00